Taking A Break - No Planned Litters for 2026
Genetic testing is one of the most valuable tools available to responsible breeders. For Golden Retrievers, it plays a vital role in preventing hereditary diseases, improving overall breed health, and ensuring that every puppy begins life with the strongest possible foundation.
Through DNA testing, breeders can identify clear, carrier, and affected dogs for specific genetic conditions. This knowledge allows for informed breeding decisions that eliminate or significantly reduce the risk of producing affected puppies.
Below is a detailed overview of the key genetic tests recommended for Golden Retrievers.
Progressive Retinal Atrophy (PRA) is a group of inherited eye diseases that lead to gradual vision loss and eventual blindness. PRA is not curable, but it is entirely preventable through responsible breeding practices.
There are three known genetic variants of PRA relevant to the Golden Retriever breed:
GR-PRA1 and GR-PRA2
These two Golden Retriever–specific mutations cause degeneration of the retina over time.
Dogs with one copy (carriers) show no symptoms but can pass the gene to their offspring.
Breeding two carriers together can produce affected puppies, so it is essential to pair carriers only with genetically clear mates.
PRA-prcd (Progressive Rod-Cone Degeneration)
This separate PRA mutation also causes progressive blindness.
Testing identifies whether a dog is clear, a carrier, or affected.
Responsible breeders use these results to prevent two carriers from being bred together.
Key Takeaway:
All Golden Retrievers in a breeding program should be tested for GR-PRA1, GR-PRA2, and PRA-prcd to safeguard future generations from preventable vision loss.
Golden Retriever Muscular Dystrophy (GR-MD) is a severe and progressive muscle-wasting disease that typically appears in young males. Symptoms include muscle weakness, stiffness, and difficulty walking.
Affected dogs experience a decline in muscle function and strength.
DNA testing identifies carriers and affected dogs early, allowing breeders to make informed mating choices that prevent the disease from spreading.
This condition is rare but devastating, making GR-MD testing a cornerstone of ethical breeding.
Neuronal Ceroid Lipofuscinosis (NCL) is a fatal neurological disorder that affects the brain and nervous system.
Symptoms usually begin in early adulthood and include tremors, seizures, behavioral changes, and loss of coordination.
There is no cure, and the disease progresses rapidly.
Genetic testing is the only way to ensure breeding dogs are not carriers of this mutation.
Testing for GR-NCL is critical to prevent this heartbreaking condition from appearing in offspring.
Ichthyosis is a hereditary skin disorder that causes flaky, scaly skin resembling fish scales. While it is not life-threatening, it can cause chronic discomfort and recurring skin issues.
ICH1 (Ichthyosis Type 1)
Typically results in mild, cosmetic skin flaking.
Dogs with this mutation can still live comfortably with proper skincare.
ICH2 (Ichthyosis Type 2)
A newer and often more severe variant.
Affected dogs may suffer from persistent dryness, itching, or secondary infections.
Testing for both ICH1 and ICH2 allows breeders to pair dogs appropriately, reducing the occurrence of this condition in future litters.
Degenerative Myelopathy (DM) is a progressive neurological disorder similar to ALS in humans. It affects the spinal cord, causing hind limb weakness, difficulty walking, and eventual paralysis.
Not all dogs carrying the DM gene will develop the disease, but testing remains essential.
Breeding carriers to clear dogs can prevent affected puppies while maintaining genetic diversity.
Responsible breeders screen all potential breeding dogs for DM and use the results thoughtfully in pairing decisions.
Genetic testing benefits breeders, owners, and most importantly, the dogs themselves. It helps ensure each litter is the result of informed, ethical decisions that protect the breed’s long-term health.
1. Preventing Hereditary Diseases
By identifying carriers and affected dogs before breeding, genetic testing eliminates the risk of passing harmful mutations to puppies.
2. Improving Breed Health
Over time, consistent genetic screening improves the overall vitality, longevity, and quality of life for Golden Retrievers as a breed.
3. Building Transparency and Trust
Providing genetic test results to prospective puppy families demonstrates honesty and accountability, strengthening your reputation as a responsible breeder.
To successfully integrate genetic testing into your breeding program:
Test Both Parents
Always test both the sire and dam before breeding to determine their genetic status for all relevant conditions.
Avoid Carrier-to-Carrier Pairings
Carriers can safely be bred to clear dogs, but never to another carrier. This prevents affected puppies while maintaining genetic diversity in the line.
Keep Detailed Records
Maintain organized records of all genetic test results and include them in each dog’s permanent health documentation.
Educate Puppy Families
Provide copies of genetic results to new owners and explain what each test means. Educating families fosters understanding and confidence in your breeding program.
Genetic testing is an indispensable part of responsible Golden Retriever breeding. It enables breeders to make educated, ethical choices that reduce the risk of hereditary disease and improve the health of future generations.
By implementing comprehensive DNA testing, including GR-PRA1, GR-PRA2, PRA-prcd, GR-MD, GR-NCL, ICH1, ICH2, and DM, you help ensure that each puppy carries forward the Golden Retriever’s legacy of soundness, intelligence, and gentle temperament.
At LMU Goldens, every breeding dog undergoes full-panel DNA testing, and results are made available to our puppy families for complete transparency. This dedication to health is what sets our program apart and supports our lifelong commitment to the breed we love.